• 
  Olivier Thouvenin, Jules Scholler, Diana Mandache, Marie Christine Mathieu, Aïcha Ben Lakhdar, et al.. Automatic diagnosis and biopsy classification with dynamic Full-Field OCT and machine learning. 2021. ⟨hal-03781375⟩
• 
  Maud Voisin, Philippe de Médina, Arnaud Mallinger, Florence Dalenc, Emilie Huc-Claustre, et al.. Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor. Proceedings of the National Academy of Sciences of the United States of America, 2017, 114 (44), pp.E9346-E9355. ⟨10.1073/pnas.1707965114⟩. ⟨hal-02316171⟩
• 
  Faten Merhi, Karla Alvarez-Valadez, Jenifer Trepiana, Claire Lescoat, Alexis Groppi, et al.. Targeting CAMKK2 and SOC Channels as a Novel Therapeutic Approach for Sensitizing Acute Promyelocytic Leukemia Cells to All-Trans Retinoic Acid. Cells, 2021, 10 (12), pp.3364. ⟨10.3390/cells10123364⟩. ⟨hal-03457279⟩
• 
  Giuseppe Arena, Madi Yann Cisse, Samuel Pyrdziak, Laurent Chatre, Romain Riscal, et al.. Mitochondrial MDM2 regulates respiratory complex i activity independently of p53. Molecular Cell, 2018, 69 (4), pp.594-609. ⟨10.1016/j.molcel.2018.01.023⟩. ⟨hal-01837662⟩
• 
  Aygun Imanci. L'implication des suppresseurs de tumeur, TET2 et TP53, dans l'évolution et le traitement de la Leucémie myélomonocytaire Chronique. Cancer. Université Paris-Saclay, 2023. Français. ⟨NNT : 2023UPASL113⟩. ⟨tel-04485463⟩
• 
  Pascal-Alexandre Thomas, Anne-Laure Couderc, David Boulate, Laurent Greillier, Aude Charvet, et al.. Early-stage non-small cell lung cancer beyond life expectancy: Still not too old for surgery?. Lung Cancer, 2021, 152, pp.86-93. ⟨10.1016/j.lungcan.2020.12.009⟩. ⟨hal-03526487⟩
• 
  Dorian Culié, Quentin Lisan, Charlotte Leroy, Anouchka Modesto, Renaud Schiappa, et al.. Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric study. European journal of cancer, 1970, 143, pp.168-177. ⟨10.1016/j.ejca.2020.10.034⟩. ⟨hal-03618860⟩
• 
  Jean-Emmanuel Kurtz, Xavier Buy, Frédéric Deschamps, Erik Sauleau, Amine Bouhamama, et al.. CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment. European Journal of Cancer, 2021, 143, pp.78-87. ⟨10.1016/j.ejca.2020.10.035⟩. ⟨hal-03623642⟩
• 
  Sylvain Manfredi, Anthony Turpin, David Malka, Emilie Barbier, Pierre Laurent-Puig, et al.. Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III study. Digestive and Liver Disease, 2020, 52 (10), pp.1143-1147. ⟨10.1016/j.dld.2020.06.034⟩. ⟨hal-04548048⟩
• 
  Sarah Atallah, Odile Casiraghi, Nicolas Fakhry, Michel Wassef, Emmanuelle Uro-Coste, et al.. A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors. European journal of cancer, 2020, 130, pp.241-249. ⟨10.1016/j.ejca.2020.01.023⟩. ⟨hal-03599053⟩
• 
  F. Mosele, B. Stefanovska, A. Lusque, A. Tran Dien, I. Garberis, et al.. Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer. Annals of Oncology, 2020, 31 (3), pp.377-386. ⟨10.1016/j.annonc.2019.11.006⟩. ⟨hal-04522293⟩
• 
  Nicolas Penel, Olivier Mir, Jennifer Wallet, Isabelle Ray-Coquard, Axel Le Cesne, et al.. A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib. European Journal of Cancer, 2020, 126, pp.45-55. ⟨10.1016/j.ejca.2019.12.001⟩. ⟨hal-03623680⟩
• 
  Liana Hardy, Brindha Kannan, Manuel Rigon, Genevieve Benton-Hawthorn, Renato Previdelli, et al.. Canine Mammary Tumours (CMTs) exploit Mitochondrial Cholesterol for aggressive reprogramming. Biochimica et Biophysica Acta - Molecular Basis of Disease, 2024, 1871 (2), pp.167546. ⟨10.1016/j.bbadis.2024.167546⟩. ⟨hal-04805257⟩
• 
  Manuel Rigon, Luciano Mutti, Michelangelo Campanella. Pleural mesothelioma ( PMe ): The evolving molecular knowledge of a rare and aggressive cancer. Molecular Oncology, 2024, 18 (4), pp.797-814. ⟨10.1002/1878-0261.13591⟩. ⟨hal-04798641⟩
• 
  C. Valenza, D. Trapani, François-Clément Bidard, J. Gligorov, J. Cortés, et al.. Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access?. ESMO Open, 2024, 9 (9), ⟨10.1016/j.esmoop.2024.103701⟩. ⟨hal-04724647⟩
• 
  Johanna Mondesir, Margherita Ghisi, Laura Poillet, Robert Bossong, Oliver Kepp, et al.. AMPK activation induces immunogenic cell death in AML. Blood Advances, In press, ⟨10.1182/bloodadvances.2022009444⟩. ⟨hal-04291063v2⟩
• 
  Nora Fajri, Nataliya Petryk. Monitoring and quantifying replication fork dynamics with high-throughput methods. Communications Biology, 2024, 7 (1), pp.729. ⟨10.1038/s42003-024-06412-1⟩. ⟨hal-04728891⟩
• 
  Yingping Li, Emilie Chouzenoux, Shuiping Gou, Peng Zeng, Samy Ammari, et al.. ComBat-MLE: A novel perspective on developing and solving ComBat harmonization method. IEEE Medai 2024 - The second IEEE international conference on medical artificial intelligence, Nov 2024, Chongqing, China. ⟨hal-04781022⟩
• 
  Bertrand Routy, Lisa Derosa, Laurence Zitvogel, Guido Kroemer. COVID-19: a challenge for oncology services. OncoImmunology, 2020, 9 (1), ⟨10.1080/2162402X.2020.1760686⟩. ⟨hal-03150177⟩
• 
  Sissel Dyrstad, Maria Lotsberg, Tuan Zea Tan, Ina Pettersen, Silje Hjellbrekke, et al.. Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells. Cancers, 2021, 13 (5), pp.941. ⟨10.3390/cancers13050941⟩. ⟨hal-03434234⟩

2 563

2 562